1. Phase 1 study of pembrolizumab plus chemotherapy as first-line treatment in Japanese patients with advanced NSCLC. (2021) Authors: Kurata, Takayasu; Nakagawa, Kazuhiko; Satouchi, Miyako; Seto, Takashi; Sawada, Takeshi; Han, Shirong; Homma, Masae; Noguchi, Kazuo; Nogami, Naoyuki Journal: Cancer treatment and research communications Issue: Number 29(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗